TABLE 1.

Clinical and Pathologic Findings in BRAF mutated GIST patients

	Age/Sex	Primary Tumor Size (cm)	Primary Tumor Site	MF/50 HPF	Stage at presentation	CD117	PTEN	P16	LFU/mo
1a	52/F	10	SB	90	Periton Mets	P	P	N	DOD/18
2	55/F	10	SB	5	Primary	P	NA	NA	NED/9
3	49/F	9	SB	50	Primary	P	P	P	NED/13
4b	66/M	20	Stomach	68	Primary	N	N	N	NED/32

F, female; M, male; cm, centimeters; SB, small bowel; periton mets, peritoneal metastases; MF, mitotic figures; HPF, high power fields; P, positive; N, negative; DOD, dead of disease; NED, no evidence of disease; AWD, alive with disease; NA, not available, LFU, last follow-up; mo, months.

^aGenotyping on normal tissue as well.

^bImatinib resistant GIST.